首页 | 本学科首页   官方微博 | 高级检索  
     检索      

A:L1型鸭源多杀性巴氏杆菌灭活疫苗制备及免疫效力研究
引用本文:田宇杰,李婷,代国滔,蒲龄,张亚楠,袁超,杨茂生,陈强,李美娟,徐景峨.A:L1型鸭源多杀性巴氏杆菌灭活疫苗制备及免疫效力研究[J].中国畜牧兽医,2022,49(7):2716-2724.
作者姓名:田宇杰  李婷  代国滔  蒲龄  张亚楠  袁超  杨茂生  陈强  李美娟  徐景峨
作者单位:1. 贵州省农业科学院畜牧兽医研究所, 贵阳 550005;2. 贵州省农业科学院草业研究所, 贵阳 550006
基金项目:贵州省科技计划项目(黔科合支撑[2019]2287号);财政部和农业农村部:国家现代农业产业技术体系;贵州省科技计划项目(黔科合平台人才[2019]5203号)
摘    要:【目的】制备鸭多杀性巴氏杆菌灭活疫苗,有效控制贵州省鸭多杀性巴氏杆菌发生和流行。【方法】以实验室分离保存的A:L1型多杀性巴氏杆菌地方流行株为菌种,通过涂板法测定该菌株生长曲线,并采用改良寇氏法计算该菌株对鸭的半数致死量(median lethal dose,LD50),将该菌培养至终浓度为1×1010 CFU/mL后分别制备白油佐剂灭活疫苗和卡波姆佐剂灭活疫苗,经疫苗质量检验后进行免疫雏鸭试验;通过攻毒保护试验评价比较两种疫苗的保护率,并对攻毒试验鸭肝脏、肺脏、脾脏进行病理组织学观察。【结果】A:L1型多杀性巴氏杆菌疫苗株培养至18 h到达峰值,活菌数可达1.0×1010 CFU/mL;LD50为5 CFU;制备的两种疫苗安全性良好;攻毒保护试验结果显示,一免后卡波姆佐剂灭活疫苗免疫保护率可达62.5%,高于白油佐剂灭活疫苗(50.0%)及商品灭活疫苗(50.0%)。二免后卡波姆佐剂灭活疫苗优势更为明显,免疫保护率可达87.5%,高于白油佐剂灭活疫苗(75.0%)及商品灭活疫苗(62.5%)。病理组织学结果显示,一免后卡波姆佐剂灭活疫苗能对肺脏提供较好的保护效果,二免后在肝脏、肺脏和脾脏的保护效果上,卡波姆佐剂灭活疫苗组优势明显。【结论】利用贵州地区流行的A:L1型菌株所制备的卡波姆佐剂灭活疫苗免疫效果明显,能对贵州地区多杀性巴氏杆菌病的防控起到重要作用。

关 键 词:鸭多杀性巴氏杆菌  A:L1型  免疫保护  灭活疫苗  
收稿时间:2022-02-22

Preparation and Immunological Study of Inactived Vaccine of Type A: L1 Pasteurella multocida from Ducks
TIAN Yujie,LI Ting,DAI Guotao,PU Ling,ZHANG Yanan,YUAN Chao,YANG Maosheng,CHEN Qiang,LI Meijuan,XU Jinge.Preparation and Immunological Study of Inactived Vaccine of Type A: L1 Pasteurella multocida from Ducks[J].China Animal Husbandry & Veterinary Medicine,2022,49(7):2716-2724.
Authors:TIAN Yujie  LI Ting  DAI Guotao  PU Ling  ZHANG Yanan  YUAN Chao  YANG Maosheng  CHEN Qiang  LI Meijuan  XU Jinge
Institution:1. Institute of Animal Husbandry and Veterinary Medicine, Guizhou Academy of Agricultural Sciences, Guiyang 550005, China;2. Institute of Pratacultural, Guizhou Academy of Agricultural Sciences, Guiyang 550006, China
Abstract:【Objective】 The inactivated Pasteurella multocida vaccine was prepared to effectively control the occurrence and prevalence of Pasteurella multocida in ducks in Guizhou province.【Method】 The local epidemic strain of A:L1 type Pasteurella multocida,isolated and preserved in the laboratory,was used as the strain.The growth curve of the strain was determined by the plating method and the median lethal dose (LD50) was calculated by improved Karber's method.After the bacteria were cultured to a final concentration of 1×1010 CFU/mL,the oil adjuvant inactivated vaccine and carbomer adjuvant inactivated vaccine were prepared respectively,and then the immunized duckling test was conducted after the vaccine's quality was inspected.The protection rate of the two vaccines were evaluated and compared by the challenge protection test,and the histopathological observation was performed on the liver,lung and spleen of the ducks in the challenge test.【Result】 The vaccine strain of A:L1 type Pasteurella multocida reached to the higestaed after 18 h,the concentration of viable bacteria was reached to 1.0×1010 CFU/mL,and the LD50 was reached to 5 CFU.The safety of the two vaccines was qualified.The challenge protection test results showed that after first immunization,the immune protection rate of the carbomer adjuvant inactivated vaccine could reached 62.5%,which was higher than that of the oil adjuvant inactivated vaccine (50.0%) and the commercial inactivated vaccine (50.0%).After the second immunization,carbomer adjuvant inactivated vaccine had obvious advantages,and the immune protection rate could reached 87.5%,which was higher than that of oil adjuvant inactivated vaccine (75.0%) and commercial inactivated vaccine (62.5%).The histopathological results showed that carbomer adjuvant inactivated vaccine could provide best protective effects on the lung after the first immunization,and in terms of the protective effects of liver,lung and spleen after the second immunization,the carbomer adjuvant inactivated vaccine group had obvious advantages.【Conclusion】 The carbomer adjuvant inactivated vaccine prepared by using the A:L1 strains prevalent in Guizhou had obvious immune effects,which could play an important role in the prevention and control of Pasteurellosis multocida in Guizhou.
Keywords:duck Pasteurella multocida  type A:L1  immune protection  inactived vaccine  
点击此处可从《中国畜牧兽医》浏览原始摘要信息
点击此处可从《中国畜牧兽医》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号